Trifecta Capital Advisors’s CME Group CME Stock Holding History

Trifecta Capital Advisors’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$174K	Buy	591 +486	+463%	+$144K	0.03%	112
2025 Q4	$28.6K	Sell	105 -8	-7%	-$2.17K	﹤0.01%	186
2025 Q3	$30.4K	Hold	113	–	–	﹤0.01%	190
2025 Q2	$31K	Buy	113 +42	+59%	+$11.4K	0.01%	194
2025 Q1	$18.7K	Buy	71 +1	+1%	+$247	﹤0.01%	191
2024 Q4	$16.2K	Hold	70	–	–	﹤0.01%	197
2024 Q3	$15.4K	Buy	70 +1	+1%	+$207	﹤0.01%	202
2024 Q2	$13.7K	Sell	69 -6,106	-99%	-$1.26M	﹤0.01%	206
2024 Q1	$1.33M	Buy	6,175 +159	+3%	+$33.4K	0.32%	55
2023 Q4	$1.27M	Buy	6,016 +105	+2%	+$22.4K	0.35%	52
2023 Q3	$1.18M	Sell	5,911 -34	-0.6%	-$6.76K	0.38%	51
2023 Q2	$1.1M	Hold	5,945	–	–	0.35%	54
2023 Q1	$1.14M	Buy	5,945 +117	+2%	+$21.2K	0.4%	54
2022 Q4	$980K	Buy	+5,828	New	+$1.01M	0.39%	59

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Trifecta Capital Advisors's CME Position: Q1 2026 in Review

Trifecta Capital Advisors increased its CME Group (CME) stake by 463% in Q1 2026, buying an estimated $144K and bringing the position to 591 shares worth $174K. The position accounts for 0.03% of the portfolio, ranked #112.

Trifecta Capital Advisors first reported a position in CME in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.33M in Q1 2024. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Trifecta Capital Advisors held 591 shares of CME Group worth $174K as of Q1 2026.
Trifecta Capital Advisors bought 486 CME Group shares in Q1 2026, an estimated $144K.
CME Group made up 0.03% of Trifecta Capital Advisors's portfolio in Q1 2026, its #112 holding.
Trifecta Capital Advisors first reported a position in CME Group in Q4 2022 and has held it in 14 quarters since.
Trifecta Capital Advisors's CME Group position peaked at $1.33M in Q1 2024.
1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Trifecta Capital Advisors's 13F filing for Q1 2026, filed 1 May 2026.